MedTrace Logo

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

NCT05351216 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2025-06-27

No results posted yet for this study

Summary

To research and explore the antibody protection and immune memory after vaccination in children with KHE during sirolimus administration. To explore the feasibility (safety and efficacy) of vaccination in a timely manner during the administration of sirolimus in children with KHE. To search for back-up plans for vaccination regimens for KHE patients taking sirolimus in children who do not respond to primary vaccination.

Conditions

  • Kaposiform Hemangioendothelioma

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Kai Li, PhD · Children's Hospital of Fudan University

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2026-03-31
Completion
2028-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05351216 on ClinicalTrials.gov